# Ambagon Therapeutics Inc. — Form D/A

Ambagon Therapeutics Inc. of Eindhoven, P7, a company, filed a Form D amendment with the SEC on 2022-06-01. The offering totals $85.0M, of which $45.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-06-01
- Form: D/A
- Accession: 0001819934-22-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $85.0M
- Amount sold: $45.0M
- Remaining: $40.0M
- Investors: 9
- Date of first sale: 2022-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-429995

## Issuer

- Name: Ambagon Therapeutics Inc.
- CIK: 0001819934
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: De Lismortel 31, Catalyst Business Ctr, Eindhoven, P7, 5612 AR
- Phone: 31 40 7517694

## Officers, directors & promoters (15)

| Name | Role | Location |
| --- | --- | --- |
| Michelle Arkin | Director | San Francisco, CA |
| Roel Bulthuis | Director | San Francisco, CA |
| Margarita Chavez | Director | San Francisco, CA |
| Scott Clarke | Director | San Francisco, CA |
| Peter Dudek | Director | San Francisco, CA |
| Janwillem Naesens | Director | San Francisco, CA |
| Adam Rosenberg | Director | Wilmington, DE |
| Scott Clarke | Executive Officer | San Francisco, CA |
| Bryan Miller | Executive Officer | Guaynabo, PR |
| Nancy Pryer | Executive Officer | San Francisco, CA |
| Melissa McCracken | Director | Eindhoven, P7 |
| Josh Seidenfeld | Executive Officer | Palo Alto, CA |
| Christian Ottmann | Executive Officer | Eindhoven, P7 |
| Michelle Arkin | Executive Officer | San Francisco, CA |
| Lucas Brunsveld | Executive Officer | San Francisco, CA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-02-07](https://search.stillhousedata.com/formd/0001819934-25-000001) | D | $12.0M | $5.0M |
| [2022-01-19](https://search.stillhousedata.com/formd/0001819934-22-000001) | D | $85.0M | $45.0M |
| [2021-12-22](https://search.stillhousedata.com/formd/0001819934-21-000003) | D/A | $5.4M | $5.4M |
| [2021-08-20](https://search.stillhousedata.com/formd/0001819934-21-000001) | D/A | $5.4M | $5.4M |
| [2020-08-03](https://search.stillhousedata.com/formd/0001819934-20-000001) | D | $7.2M | $7.2M |

## More

- [CIK 1819934 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1819934&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001819934-22-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.